Baxter starts late-stage stem cell study CBS News The trial will evaluate the stem cell transplant as a treatment for chronic myocardial ischemia, a severe type of coronary artery disease. Baxter said it will enroll 450 patients in the trial, and the patients will receive either the stem cell ... |
